Actively Recruiting
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
Led by Endomagnetics Ltd. · Updated on 2026-03-16
184
Participants Needed
2
Research Sites
184 weeks
Total Duration
On this page
Sponsors
E
Endomagnetics Ltd.
Lead Sponsor
E
Endomagnetics Inc
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to provide prospective evidence in the US population of the frequency of skin discoloration and Sentinel Lymph Node detection rate in patients who have recevied Magtrace for Sentinel Lymph Node Biopsy (SLNB) and to evaluate the impact that skin discoloration has on patients when it does occur using patient reported outcome measures.
CONDITIONS
Official Title
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient is willing and able to give informed consent for participation in the study
- Patient is aged 18 years or older at the time of consent
- Patients undergoing planned breast conserving surgery (for example, lumpectomy or partial mastectomy) and SLNB with Magtrace
You will not qualify if you...
- The patient is pregnant or lactating
- The patient has had prior breast radiation to the ipsilateral breast
- The patient has clinical or radiological evidence of metastatic cancer including palpably abnormal or enlarged lymph nodes
- The patient has received a Feraheme (ferumoxytol) injection within the past 6 months
- The patient has intolerance or hypersensitivity to iron or dextran compounds or to Magtrace
- The patient has iron overload disease
- The patient has discoloration on the breast (such as tattoo, birthmark, tanning, rash etc.) that could impact the assessment of skin discoloration, or plans to have a tattoo on the breast after surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
UNC, Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States, 27599
Actively Recruiting
2
VCU Massey Comprehensive Cancer Center
Richmond, Virginia, United States, 23298
Actively Recruiting
Research Team
V
Vicky Crawford
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here